Tiny doses, big questions: how does the body handle this prodrug?
Knowledge-focused
Completed
Researchers are testing how the body absorbs and processes a microdose of PRX-P4-003, a prodrug designed to release the active compound (-)-fencamfamine. Six healthy men receive a single oral microdose of PRX-P4-003 and, separately, a single oral dose of the active compound itsel…
Early phase 1 • Sponsor: Praxis Bioresearch, LLC • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC